Fool.com
The World's Greatest Investing Community
Results 21 - 30 of 428 : Previous 1 2 3 4 5 6 7 8 9 Next
The Billion-Dollar Lovers' Quarrel Continues
Elan had better bring candy and flowers to patch this up.
Pfizer's Paying $2.3 Billion Again? Oh, Wait, Never Mind.
Get past the headline, Fools.
Pharma's Next Home Run Drug Could Be 4 Singles Instead
With mixed success in the women's health field, drugmakers try to turn a single compound into a treatment for several diseases and conditions.
Merck to Bride: Leave the Jewelry at Home
Merck reorganizes.
UnitedHealth lowers costs through an adherence-incentive program.
Moving Orencia up the pecking order.
It's Not Too Late to Save Your Retirement
No matter your age, there are still things you can do to improve your retirement.
2-Star Stocks Poised to Plunge: Warner Chilcott?
Market-lagging returns could be written in these two stars.
How to Keep From Losing Your Shirt
More side effects for weight-loss drugs -- maybe.
These stocks are reaching for the stars.
Legal Information © 1995 - 2009 The Motley Fool. All rights reserved.
Market Data provided by 
Terms & Conditions
RSS Headlines
Fool UK